Home
>
National Drug Code (NDC)
>
PEPCID
PEPCID - 0006-0963-31 - (famotidine)
Drug Information of PEPCID
| Product NDC: | 0006-0963 |
| Proprietary Name: | PEPCID |
| Non Proprietary Name: | famotidine |
| Active Ingredient(s): | 20 mg/1 & nbsp; famotidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PEPCID
| Product NDC: | 0006-0963 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019462 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19861015 |
Package Information of PEPCID
| Package NDC: | 0006-0963-31 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0963-31) |
NDC Information of PEPCID
| NDC Code | 0006-0963-31 |
| Proprietary Name | PEPCID |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0963-31) |
| Product NDC | 0006-0963 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | famotidine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19861015 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | FAMOTIDINE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
